By: Andrew Yoon, M.D., medical director, Heart Failure, MemorialCare Heart & Vascular Institute at Long Beach Medical Center.
MemorialCare Heart & Vascular Institute at Long Beach Medical Center is one of only two medical centers in California selected to participate in the RESPONDER-HF confirmatory trial, a global clinical study evaluating the Corvia® Atrial Shunt. This first-of-its-kind device is designed to treat heart failure with preserved ejection fraction (HFpEF), often referred to as “heffpeff” heart failure—a condition characterized by sudden, debilitating shortness of breath with minimal physical activity.
HFpEF is among the most challenging forms of heart failure to manage. Many patients continue to struggle despite optimal medical therapy, making everyday activities feel insurmountable. The Corvia Atrial Shunt offers a targeted, device-based solution opening blood flow in the heart to give patients back their ability to breathe, which once felt insurmountable for heff-peff patients…